Fig. 9: TRPM7-SLC2A3 axis is conserved across cancer and endothelial cells.
From: The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis
TRPM7 regulates SLC2A3 to drive tumorigenesis and angiogenesis via ca2+/calcineurin/CRTC2/CREB axis.
